Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) traded at $8.24 at last check on Tuesday, Jun 30, making an upward move of 4.17% on its previous day’s price.
Looking at the stock we see that its previous close was $7.91 and the beta (5Y monthly) reads 1.41 with the day’s price range being $7.95 – 8.40. In terms of its 52-week price range, CRBP has a high of $8.66 and a low of $3.29. The company’s stock has gained about 6.03% over that past 30 days.
On the other hand, looking at the outlook for the CRBP stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Let’s briefly compare Corbus (CRBP) stock to its peers. We find that today’s price change of +4.17% and +14.14% over the past 12 months for CRBP competes that of Zoetis Inc Cl A (ZTS), which has seen its stock price rise 2% in the latest trading session and is +16.29% over the last one year. Another of its peers Takeda Pharmaceutical Co. Ltd (TAK) has dropped -1.91% today, and is +2.32% up over the past year, while Grifols S.A. (GRFS) is also up 4.17% yet its price remains in the green at 14.14% over the same period. Zoetis has a P/E ratio of 39.26 compared to Corbus’ 0 and Takeda’s 22.32. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.04% and 0.46%, respectively, in early deals.
Coming back to Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), we note that the average 3-month trading volume was 1.22 Million, while that of the preceding 10-day period stands at 1.84 Million. Current shares outstanding are 72.49 Million.
According to data from Thomson Reuters, insiders hold 4.93% of the company’s shares while institutions hold 41.18%. The data shows that short shares as of June 14, 2020, stood at 11.43 Million at a short ratio of 7.82. This represents a 15.76% Short interest in Shares outstanding on June 14, 2020. Shares short dropped in June from the previous month at 11.79 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +44.87% up in year-to-date price movement.